RTSN

Retension Pharmaceuticals, Inc.

Nasdaq· CIK 0002002988 Biotech & Drug Discovery

$14.55 −0.70 (−4.62%)

Oct 26 4:00 PM ET · prev $15.25

Market cap

$122.2M

Micro cap

Since first trade

+38.1%

from $10.53 · Oct 9

30 days

+38.1%

from $10.53

Range since listing

$10.53–16.33

−11% from high · low Oct 9

Avg volume 12D

184.4K

Oct 9 spike 789.2K

Insider net

+$369.6K

2 buyers · 0 sellers · 12 mo

Filing reports

analyzed by SecBot

SecBot read MIXED 18 reports · 90 days

Balance 0 bearish · 2 bullish · 16 neutral oldest → newest, height = score

Avg score

·High conf. 16/18

Strongest BULLISH The SEC declared effective Retension Pharmaceuticals' S-1 registration statement for its initial public…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Oct 9 The SEC declared effective Retension Pharmaceuticals' S-1 registrati…
B Oct 13 2 insiders buy $369.6K at $12.00

Signal stack

Where each data set points today.

InsidersBULLISH

2 insiders bought $369.6K at an average $12.00. No open-market sales. Price is 21% above their cost.

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Oct 22, 2026 SEC

Retension Pharmaceuticals appointed Robert Wong as Vice President, Chief Accounting Officer (Principal Accounting…

8-K — Impact 2/10

Oct 22, 2026 Insider

Keller Eric L. was granted 40,884 shares

CHIEF EXECUTIVE OFFICER

Oct 16, 2026 SEC

B Group, Inc., B Group Capital LLC, and Branden B. Muhl filed a Schedule 13G disclosing passive beneficial ownership…

SC 13G — Impact 4/10

Oct 16, 2026 SEC

PVG Asset Management Corp disclosed a passive 8.3% stake in Retension Pharmaceuticals via a Schedule 13G filed October…

SC 13G — Impact 3/10

Oct 13, 2026 Insider

BERGER FRANKLIN M acquired 12,517 shares

Director

Oct 13, 2026 Insider

BERGER FRANKLIN M bought 10,000 shares

Director @ $12.00 ($120.0K)

Oct 12, 2026 Listing status

New Listing: RTSN — Retension Pharmaceuticals, Inc. - Common Stock

Listed on exchange Q

Insider ledger

Form 4

$369.6K

bought · 2 insiders

sold · 0 insiders

+21.2%

vs their $12.00 cost

Date	Insider	Type	Value
Oct 22, 2026	Keller Eric L. CHIEF EXECUTIVE OFFICER	AWARD	40,884 sh
Oct 13, 2026	BERGER FRANKLIN M Director	CONVERT	12,517 sh
Oct 13, 2026	BERGER FRANKLIN M Director	BUY	$120.0K
Oct 13, 2026	BERGER FRANKLIN M Director	CONVERT	12,517 sh
Oct 13, 2026	BERENDT MICHAEL J Director	CONVERT	4,026 sh
Oct 13, 2026	BERENDT MICHAEL J Director	CONVERT	2,640 sh
Oct 13, 2026	BERENDT MICHAEL J Director	CONVERT	4,026 sh
Oct 13, 2026	BERENDT MICHAEL J Director	CONVERT	2,640 sh